NEWMARKET BIOMEDICAL LIMITED Financials
- Company number
- 07500738Copy
Copy - Registered office
- Unit 1 Lanwades Business Park, Kentford, Suffolk CB8 7PN
- Incorporated
- 21/01/2011
Company snapshot
- Status
- Active
- Employees
- 15 (2025)
- Latest financial data
- 2025
- Accounts type
- Total Exemption Full
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2025.
Net Assets
-33.08%vs 20242024: £1.90M
Total Assets
-23.16%vs 20242024: £2.25M
Cash in Bank
-64.99%vs 20242024: £1.06M
Total Liabilities
29.78%vs 20242024: £355.17K
Employees
+2vs 20242024: 13
In 2025, NEWMARKET BIOMEDICAL LIMITED reported net assets of £1.27M. The same filing shows total assets of £1.73M, cash in bank of £371.44K and total liabilities of £460.94K. Reported headcount was 15 in 2025. Cash in Bank fell from £1.06M in 2024 to £371.44K in 2025 (-64.99%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
-33.08%from £1.90M in 2024Year-on-year change
Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures NEWMARKET BIOMEDICAL LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
-34.2%vs 2023-18.9% a year compound (CAGR)
Cash in Bank
-63.5%vs 2023-39.6% a year compound (CAGR)
Total Assets
-21.2%vs 2023-11.2% a year compound (CAGR)
Total Liabilities
+72.4%vs 2023+31.3% a year compound (CAGR)
Employees
+25%vs 2023+3Biggest increase
Total Liabilities+72.4%
£267.31K in 2023 to £460.94K in 2025
Biggest decrease
Cash in Bank-63.5%
£1.02M in 2023 to £371.44K in 2025
NEWMARKET BIOMEDICAL LIMITED's filings pull in both directions between 2023 and 2025. The steepest rise came in total liabilities, pointing to heavier outstanding obligations, set against a fall in cash in bank, pointing to a tighter cash position. See the full year-by-year figures.
Ratios from the filed figures
Calculated from NEWMARKET BIOMEDICAL LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 73.35%2025
- Liabilities to total assets
- 26.65%2025
- Cash to liabilities
- 80.58%2025
- Cash to total assets
- 21.47%2025
Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for NEWMARKET BIOMEDICAL LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Assets£ | 741.18K | 940.39K | 1.93M | 1.90M | 1.27M |
| Total Assets£ | 840.50K | 1.05M | 2.20M | 2.25M | 1.73M |
| Cash in Bank£ | 322.75K | 385.74K | 1.02M | 1.06M | 371.44K |
| Total Liabilities£ | 99.31K | 107.73K | 267.31K | 355.17K | 460.94K |
| Employees | 10 | 10 | 12 | 13 | 15 |
NEWMARKET BIOMEDICAL LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Has NEWMARKET BIOMEDICAL LIMITED filed financial statements?
Yes. Okredo holds filed figures for NEWMARKET BIOMEDICAL LIMITED covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.
What net assets did NEWMARKET BIOMEDICAL LIMITED report in 2025?
NEWMARKET BIOMEDICAL LIMITED reported net assets of £1.27M for 2025. That compares with £1.90M in 2024, a change of -33.08%.
What total assets did NEWMARKET BIOMEDICAL LIMITED report in 2025?
NEWMARKET BIOMEDICAL LIMITED reported total assets of £1.73M for 2025. That compares with £2.25M in 2024, a change of -23.16%.
What cash in bank did NEWMARKET BIOMEDICAL LIMITED report in 2025?
NEWMARKET BIOMEDICAL LIMITED reported cash in bank of £371.44K for 2025. That compares with £1.06M in 2024, a change of -64.99%.
How many people does NEWMARKET BIOMEDICAL LIMITED employ?
NEWMARKET BIOMEDICAL LIMITED reported 15 employees in 2025, compared with 13 in 2024.
How have NEWMARKET BIOMEDICAL LIMITED financials changed over the last 3 years?
Between 2023 and 2025, NEWMARKET BIOMEDICAL LIMITED's net assets fell by 34.2%, cash in bank fell by 63.5%, total assets fell by 21.2% and total liabilities rose by 72.4%. Net assets contracted at 18.9% a year across the two years to 2025, from £1.93M to £1.27M. Reported headcount went from 12 in 2023 to 15 in 2025 (+3).
Which years of NEWMARKET BIOMEDICAL LIMITED financial data are available?
Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.